The Venture Intelligence Blog

Economic Times has profiles of 3 new VC-backed Life sciences companies: Cellworks Research FOUNDED: 2005 INVESTOR: Artiman Ventures ACTIVITY: Drug discovery using a proprietary computer simulation platform to find new uses for old drugs in inflammation and cancer POTENTIAL REVENUE STREAMS: Licensing drugs for development and marketing,selling its proprietary green chemistry technology to various industries Vyome Biosciences FOUNDED: 2010 ACTIVITY: Researching drugs for wound healing,skin pigmentation,finding new uses for old drugs in dandruff and acne treatments INVESTOR: Navam Capital POTENTIAL REVENUE STREAMS: Licensing drugs for development and marketing to larger companies Mitra Biotech . FOUNDED: 2009 INVESTOR: Kitven,Accel Partners,India Innovation Fund ACTIVITY: Diagnostics to personalise cancer medicine in partnership with hospitals and drug companies POTENTIAL REVENUE STREAMS: Offering testing services to cancer hospitals to match drugs to patients,partnering drug companies d...

In an article for AltAssets, Charles Fletcher of US law firm Taylor Wessing describes how, in the absence of VC funding for capital intensive projects, cleantech compannies can look at alternative financing sources, including state-sponsored finance, licensing techniques and other models of co-development, which take their cue from the biotech sector. Arun Natarajan is the Founder & CEO of Venture Intelligence, the leading provider of data and analysis on private equity, venture capital and M&A deals in India. View free samples of Venture Intelligence newsletters and reports. Email the author at arun@ventureintelligence.in